Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients

BackgroundApproximately 10–40% of people with human immunodeficiency virus (HIV) infection are unable to obtain successful improvements in immune function after antiretroviral therapy (ART). These patients are at greater risk of developing non-acquired immunodeficiency syndrome (AIDS)-related condit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun-Nan Lv, Jia-Qi Li, Ying-Bin Cui, Yuan-Yuan Ren, Ya-Jing Fu, Yong-Jun Jiang, Hong Shang, Zi-Ning Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
HIV
ART
Acceso en línea:https://doaj.org/article/5ad973286ce146879bc4e7b8b19ccf43
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ad973286ce146879bc4e7b8b19ccf43
record_format dspace
spelling oai:doaj.org-article:5ad973286ce146879bc4e7b8b19ccf432021-11-30T12:54:03ZPlasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients1664-322410.3389/fimmu.2021.753044https://doaj.org/article/5ad973286ce146879bc4e7b8b19ccf432021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.753044/fullhttps://doaj.org/toc/1664-3224BackgroundApproximately 10–40% of people with human immunodeficiency virus (HIV) infection are unable to obtain successful improvements in immune function after antiretroviral therapy (ART). These patients are at greater risk of developing non-acquired immunodeficiency syndrome (AIDS)-related conditions, with the accompanying increased morbidity and mortality. Discovering predictive biomarkers can help to identify patients with a poor immune response earlier and provide new insights into the mechanisms of this condition.MethodsA total of 307 people with HIV were enrolled, including 110 immune non-responders (INRs) and 197 immune responders (IRs). Plasma samples were taken before ART, and quantities of plasma microRNAs (miRNAs) were determined using reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). Candidate biomarkers were established through four phases: discovery, training, validation, and blinded test. Binary logistic regression was used to analyze the combined predictive capacity of the identified miRNAs. The effect of one miRNA, miR-16-5p, on T cell function was assessed in vitro.ResultsExpression of five miRNAs (miR-580, miR-627, miR-138-5p, miR-16-5p, and miR-323-3p) was upregulated in the plasma of INRs compared with that in IRs. Expression of these miRNAs was negatively correlated with both CD4+ T cell counts and the increase in the proportion of CD4+ T cells after one year of ART. These five miRNAs were combined in a predictive model, which could effectively identify INRs or IRs. Furthermore, we found that miR-16-5p inhibits CD4+ T cell proliferation by regulating calcium flux.ConclusionWe established a five-miRNA panel in plasma that accurately predicts poor immune response after ART, which could inform strategies to reduce the incidence of this phenomenon and improve the clinical management of these patients.Jun-Nan LvJun-Nan LvJia-Qi LiJia-Qi LiYing-Bin CuiYuan-Yuan RenYuan-Yuan RenYa-Jing FuYa-Jing FuYong-Jun JiangYong-Jun JiangHong ShangHong ShangZi-Ning ZhangZi-Ning ZhangFrontiers Media S.A.articleHIVimmunological non-respondersmicroRNAbiomarkerARTImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic HIV
immunological non-responders
microRNA
biomarker
ART
Immunologic diseases. Allergy
RC581-607
spellingShingle HIV
immunological non-responders
microRNA
biomarker
ART
Immunologic diseases. Allergy
RC581-607
Jun-Nan Lv
Jun-Nan Lv
Jia-Qi Li
Jia-Qi Li
Ying-Bin Cui
Yuan-Yuan Ren
Yuan-Yuan Ren
Ya-Jing Fu
Ya-Jing Fu
Yong-Jun Jiang
Yong-Jun Jiang
Hong Shang
Hong Shang
Zi-Ning Zhang
Zi-Ning Zhang
Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
description BackgroundApproximately 10–40% of people with human immunodeficiency virus (HIV) infection are unable to obtain successful improvements in immune function after antiretroviral therapy (ART). These patients are at greater risk of developing non-acquired immunodeficiency syndrome (AIDS)-related conditions, with the accompanying increased morbidity and mortality. Discovering predictive biomarkers can help to identify patients with a poor immune response earlier and provide new insights into the mechanisms of this condition.MethodsA total of 307 people with HIV were enrolled, including 110 immune non-responders (INRs) and 197 immune responders (IRs). Plasma samples were taken before ART, and quantities of plasma microRNAs (miRNAs) were determined using reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). Candidate biomarkers were established through four phases: discovery, training, validation, and blinded test. Binary logistic regression was used to analyze the combined predictive capacity of the identified miRNAs. The effect of one miRNA, miR-16-5p, on T cell function was assessed in vitro.ResultsExpression of five miRNAs (miR-580, miR-627, miR-138-5p, miR-16-5p, and miR-323-3p) was upregulated in the plasma of INRs compared with that in IRs. Expression of these miRNAs was negatively correlated with both CD4+ T cell counts and the increase in the proportion of CD4+ T cells after one year of ART. These five miRNAs were combined in a predictive model, which could effectively identify INRs or IRs. Furthermore, we found that miR-16-5p inhibits CD4+ T cell proliferation by regulating calcium flux.ConclusionWe established a five-miRNA panel in plasma that accurately predicts poor immune response after ART, which could inform strategies to reduce the incidence of this phenomenon and improve the clinical management of these patients.
format article
author Jun-Nan Lv
Jun-Nan Lv
Jia-Qi Li
Jia-Qi Li
Ying-Bin Cui
Yuan-Yuan Ren
Yuan-Yuan Ren
Ya-Jing Fu
Ya-Jing Fu
Yong-Jun Jiang
Yong-Jun Jiang
Hong Shang
Hong Shang
Zi-Ning Zhang
Zi-Ning Zhang
author_facet Jun-Nan Lv
Jun-Nan Lv
Jia-Qi Li
Jia-Qi Li
Ying-Bin Cui
Yuan-Yuan Ren
Yuan-Yuan Ren
Ya-Jing Fu
Ya-Jing Fu
Yong-Jun Jiang
Yong-Jun Jiang
Hong Shang
Hong Shang
Zi-Ning Zhang
Zi-Ning Zhang
author_sort Jun-Nan Lv
title Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
title_short Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
title_full Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
title_fullStr Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
title_full_unstemmed Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients
title_sort plasma microrna signature panel predicts the immune response after antiretroviral therapy in hiv-infected patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5ad973286ce146879bc4e7b8b19ccf43
work_keys_str_mv AT junnanlv plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT junnanlv plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT jiaqili plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT jiaqili plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yingbincui plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yuanyuanren plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yuanyuanren plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yajingfu plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yajingfu plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yongjunjiang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT yongjunjiang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT hongshang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT hongshang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT ziningzhang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
AT ziningzhang plasmamicrornasignaturepanelpredictstheimmuneresponseafterantiretroviraltherapyinhivinfectedpatients
_version_ 1718406563366961152